FC for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Bingling Guo, Qiying Li, Qingqing Huang, Xiping Liang, Chunyan Xiao, Dehong Huang, Taoyang, Wenjun Zhang, Yingyu Nan and Ying Xiang
Additional contact information
Ying Xiang: Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, China

Biomedical Journal of Scientific & Technical Research, 2019, vol. 19, issue 4, 14495-14496

Abstract: Despite overall improvements, relapsed/refractory diffuse large B-cell lymphoma (DLBCL)remains a major cause of morbidity...

Keywords: Biomedical Open Access Journals; Biomedical Journal Articles; Biomedical Journal Impact Factor; Scientific Research Articles on Biomedical; Journal of Biomedical Research and Reviews; Nano Medicine; Family Medicine; Physical Medicine and Rehabilitation; Preventive Medicine (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003344.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003344.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:19:y:2019:i:4:p:14495-14496

DOI: 10.26717/BJSTR.2019.19.003344

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().